KMDA
KMDA
NASDAQ · Biotechnology

Kamada Ltd

$7.11
-0.08 (-1.11%)
As of Jun 23, 3:10 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +308.2% upside
Low Target $25.25
Average Target $29.02
High Target $47.24
Current Price $7.11
Current
$7.11
Target
$29.02
$25.25 $29.02 avg $47.24
Scenario Analysis
Bear Case
$25.25
255.1%
Low target
Base Case
$29.02
+308.2%
Avg target
Bull Case
$47.24
+564.4%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$9.35
-24.0% from high
52-Week Low
$6.50
+9.4% from low
Target vs 52W High
$29.02
+210.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%